Grants and Contracts Details
This study is a multi-center, Phase III, randomized trial of reduced intensity conditioning followed by transplantation of two unrelated cord blood units with calcineurin inhibitor and mycophenolate mofetil (MMF) for GVHD prophylaxis versus HLA-haploidentical related bone marrow with posttransplant cyclophosphamide, calcineurin inhibitor and MMF for GVHD prophylaxis in patients with: 1) Acute lympohblastic leukemia/lymphoma, acute myelogenous leukemia, or Burkitt's lymphoma in remission. 2) Lymphoma, including marginal zone lymphoma, follicular lymphoma, or chemotherapy-sensitive large-cell, Hodgkin or mantle cell lymphoma.
|Effective start/end date||9/9/13 → 5/20/15|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.